feed

view company updates

tools

perform investment research

network

join events & discussions

advisory

about us

Redeye Capital

Cantargia: Stärkt patentskydd i USA

Research Note

2018-10-01

09:26

Cantargia har erhållit stärkt patentskydd i USA kring antikroppen CAN03.

MS

Mathias Spinnars

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.